[{"Assets_0_Q3_USD":48187000000.0,"CIK":"59478","CommonStockDividendsPerShareDeclared_3_Q3_USD":1.7,"Country":"United States","EarningsPerShareBasic_1_Q3_USD":1.22,"EarningsPerShareBasic_3_Q3_USD":4.25,"EarningsPerShareDiluted_1_Q3_USD":1.22,"EarningsPerShareDiluted_3_Q3_USD":4.23,"Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NYSE","Market Cap":"282857000000.0","NetCashProvidedByUsedInOperatingActivitiesConverted_3_Q3_USD":5104200000.0,"NetIncomeLossConverted_1_Q3_USD":1110100000.0,"NetIncomeLossConverted_3_Q3_USD":3855600000.0,"OfficialName":"Eli Lilly and Company Common Stock","RevenuesConverted_1_Q3_USD":6772800000.0,"RevenuesConverted_3_Q3_USD":20318500000.0,"SP500":"SP500","Sector":"Health Care","StockholdersEquityConverted_0_Q3_USD":7954100000.0,"StockholdersEquity_0_Q3_USD":7757000000.0,"Ticker":"LLY","WeightedAverageNumberOfDilutedSharesOutstanding_1_Q3_shares":910800000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_3_Q3_shares":911700000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":906700000.0,"WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":907700000.0,"filed":"20211027","footnote":"nan","form":"10-Q","fp":"Q3","fy":"2021.0","name":"ELI LILLY & CO","period":"20210930","qtrs":"0","uom":"USD"}]